CAS: 1018899-04-1 - Lx4211
Formula:C21H25O5ClS
InChI:InChI=1S/C21H25ClO5S/c1-3-26-15-7-4-12(5-8-15)10-14-11-13(6-9-16(14)22)20-18(24)17(23)19(25)21(27-20)28-2/h4-9,11,17-21,23-25H,3,10H2,1-2H3/t17-,18-,19+,20+,21-/m1/s1
InChI key:InChIKey=QKDRXGFQVGOQKS-CRSSMBPESA-N
SMILES:ClC1=CC=C(C=C1CC2=CC=C(OCC)C=C2)C3OC(SC)C(O)C(O)C3O
- Synonyms:
- (5S)-Methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-β-<span class="text-smallcaps">L</span>-xylopyranoside
- Lp 802034
- Lx-4211
- Sotagliflozin
- Zynquista
- β-<span class="text-smallcaps">L</span>-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-
β-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-
CAS:1018899-04-1
Formula:
C21H25ClO5S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
424.9382
Ref: AN-AG0005U7
1g | 101.00 € | |
5g | 234.00 € | |
10g | 311.00 € | |
100mg | 44.00 € | |
250mg | 50.00 € |
Estimated delivery in United States, on Friday 3 May 2024
Sotagliflozin
CAS:1018899-04-1
Sotagliflozin (LP-802034) is an orally bioavailable inhibitor of the sodium-glucose co-transporter subtype 1 (SGLT1) and …
Formula:
C21H25ClO5S
Purity:
99.37%
Color and Shape:
Solid
Molecular weight:
424.94
Ref: TM-T3547
1mg | 45.00 € | |
2mg | 56.00 € | |
5mg | 96.00 € | |
10mg | 129.00 € | |
25mg | 244.00 € | |
50mg | 369.00 € | |
100mg | 548.00 € | |
500mg | 1,175.00 € | |
1ml*10 (DMSO) | 87.00 € |
Estimated delivery in United States, on Friday 10 May 2024
LX4211
CAS:1018899-04-1
Inhibitor of sodium-glucose cotransporters SGLT1 and SGLT2
Formula:
C21H25ClO5S
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
424.94 g/mol
Ref: 3D-BL161424
25mg | 96.00 € | |
50mg | 119.00 € | |
100mg | 189.00 € | |
250mg | 340.00 € | |
500mg | 477.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
Ref: TR-S358115
100mg | 17,795.00 € |
Estimated delivery in United States, on Thursday 13 Jun 2024